Showing results (1-10 of 184) with videos related to
Sort By:
Pageof 19
Surgery|September 1, 1982
Immune modulatory effects of indomethacin in melanoma patients are not related to prostaglandin E2-mediated suppressionA B Tilden, C M BalchSurgery|July 1, 1981
Indomethacin enhancement of immunocompetence in melanoma patientsA B Tilden, C M BalchJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibodyA B Tilden, T Abo, C M BalchJournal of Immunology (Baltimore, Md. : 1950)|February 15, 1987
Human lymphokine-activated killer (LAK) cells: identification of two types of effector cellsA B Tilden, K Itoh, C M BalchCancer Research|June 1, 1986
Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomasK Itoh, A B Tilden, C M BalchCancer Research|July 1, 1985
Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cellsK Itoh, A B Tilden, C M BalchSurgery|August 1, 1985
Cellular immune defects in patients with melanoma involving interleukin-2-activated lymphocyte cytotoxicity and a serum suppressor factorC M Balch, K Itoh, A B TildenJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Lysis of human solid tumor cells by lymphokine-activated natural killer cellsK Itoh, A B Tilden, C M BalchAnnals of Surgery|December 1, 1982
Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patientsC M Balch, P A Dougherty, A B TildenJournal of Immunology (Baltimore, Md. : 1950)|February 1, 1985
Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cellsK Itoh, A B Tilden, K Kumagai, et al.Pageof 19